65685-01-0Relevant articles and documents
Synthesis method of biphenyl-3-sulfonyl chloride derivative
-
Paragraph 0067; 0075-0078; 0100-0104, (2021/10/16)
The invention discloses a synthesis method of a biphenyl-3-sulfonyl chloride derivative. According to the method, 3-bromobenzene sulfonyl chloride and a phenylboronic acid derivative which are cheap and easy to obtain are used as raw materials, and a target compound is obtained through two steps of Suzuki coupling reaction and chlorination reaction. The method not only avoids the problem that biphenyl 3-position is difficult to sulfonate, but also has the advantages of high reaction activity, simplicity and convenience in operation, lower danger coefficient of the used reagent and lower environmental pollution, and can be used as a potential route for industrial large-scale production of biphenyl sulfonic acid derivatives.
RORγ MODULATORS
-
Page/Page column 22-23; 58, (2018/04/13)
The invention provides an RORγ receptor agonist comprising a compound of formula (I), wherein the variables are as defined herein. These compounds are analogous to known RORγ receptor antagonists. The invention further provides a method of activating -the nuclear receptor RORγ, comprising -contacting the RORγ with an effective amount or concentration of a compound of the invention; and a method of treating cancer in a patient, comprising administering to the patient an effective dose of a compound of the invention.
Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
-
, (2008/06/13)
Biphenylsulfonamides and methods for modulating or altering the activity of the endothelin family of peptides are provided. In particular, bicyclic or tricyclic carbon or heterocyclic ring biphenylsulfonamides and methods using these sulfonamides for inhibiting the binding of an endothelin peptide to an endothelin receptor by contacting the receptor with the sulfonamide are provided. Methods for treating endothelin-mediated disorders by administering effective amounts of one or more of these sulfonamides or prodrugs thereof that inhibit or increase the activity of endothelin are also provided.